Clinical consequences of polymorphic acetylation of basic drugs.

Drayer, D E

Clinical consequences of polymorphic acetylation of basic drugs. [electronic resource] - Clinical pharmacology and therapeutics Sep 1977 - 251-8 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

0009-9236

10.1002/cpt1977223251 doi


Acetylation
Antibodies, Antinuclear
Biotransformation
Chemical and Drug Induced Liver Injury--etiology
Humans
Hydralazine--adverse effects
Isoniazid--adverse effects
Lupus Erythematosus, Systemic--chemically induced
Pharmaceutical Preparations--metabolism
Phenelzine--adverse effects
Phenotype
Polymorphism, Genetic
Procainamide--adverse effects
Sulfasalazine--adverse effects